-
A new drug is helping families who’ve spent years locking up or hiding food as their children with Prader-Willi syndrome deal with unrelenting hunger. But additional progress is under threat.
-
The biggest questions are whether people can still choose to receive the vaccine even if it's not recommended for them and whether insurance will cover the cost.
-
Novavax makes the nation’s only traditional protein-based coronavirus vaccine – and until now it had emergency authorization from FDA for use in anyone 12 and older. What's the change?
-
The shot has been available under emergency use since 2022 and is the nation’s only traditional protein-based option for COVID-19. Now experts are questioning whether other vaccines will be caught in the turmoil.
-
Sensient Technologies is one of the world's largest dyemakers. The company has seen a surge in businesses rushing to covert products from synthetic to natural colors. The process won't be cheap or easy.
-
Most of the 80,000 workers responsible for researching diseases, inspecting food and administering Medicare and Medicaid under Health and Human Services were emailed the separation deal.
-
Some Trump insiders are ready to take on the food industry. It remains to be seen whether their entree will result in any meaningful change in government oversight of “Big Food” — or in American health.
-
The most popular nasal decongestant on U.S. pharmacy shelves may not be there much longer. The FDA recently announced plans to phase out phenylephrine.
-
The FDA is investigating a salmonella outbreak linked to cucumbers from a grower in Mexico with the SunFed brand.
-
Johns Hopkins surgeon Dr. Marty Makary is his choice for the FDA and Dr. Janette Nesheiwat is in line to be the next surgeon general. Dr. Dave Weldon of Florida is slated to run the CDC.